glp-1 science The journey: from discovery to therapeutic impact The Science Behind the Quest

& Nangaku, M

GLP-1 medications can produce rapid weight reduction that outpaces the skins ability to adjust, creating more pronounced laxity

Lahteenvuo, M., Tiihonen, J., Solismaa, A., et al

Common areas affected include the lower abdomen (often described as an apron of skin), the upper arms, inner thighs, the chest and breasts, and the face and neck

Frustrated by a market crowded with flashy claims and under-dosed formulas, Cohen set out to build a brand grounded in research, meaningful ingredient levels, and real-world testing

Semaglutide in SUSTAIN-6 trial reduced the risk of MACE by 26% in patients with T2D, mostly by reducing rate of nonfatal stroke (39%) compared to placebo